FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:79-81 January 3, 2008 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Vadas, P. PubMed Citation

Anaphylaxis has been recognized for more than 100 years, but it remains a condition that is difficult to predict, diagnose, and treat. Generally defined as a serious allergic reaction that is rapid in onset and may cause death,¹ anaphylaxis and its potential to occur can be of great concern for patients and clinicians. Compounding this concern in the United States and other industrialized societies is the increasing incidence of food allergies, which are the leading cause of cases of anaphylaxis reported in hospital emergency departments, where there are approximately 30,000 reactions and 200 deaths from anaphylaxis each year.² The alarming . . . [Full Text of this Article]

Source Information

From the Department of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC.

This article has been cited by other articles:

• Tsoukatos, D. C., Brocheriou, I., Moussis, V., Panopoulou, C. P., Christofidou, E. D., Koussissis, S., Sismanidis, S., Ninio, E., Siminelakis, S. (2008). Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery. J. Lipid Res. 49: 2240-2249 [Abstract] [Full Text]  
• (2008). A Role for Platelet-Activating Factor in Anaphylaxis. Journal Watch Dermatology 2008: 3-3 [Full Text]